Search research articles
Contact Us
Filters
Showing results (21-30 of 162) with videos related to
Page
of 17
Sort By:
Journal of Contemporary Brachytherapy
|
April 26, 2021
Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
Wayne M Butler, Brian S Kurko, Whitney J Scholl, et al.
Oncology (Williston Park, N.Y.)
|
June 3, 2006
Permanent prostate brachytherapy: is supplemental external-beam radiation therapy necessary?
Gregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
Clinical Journal of Oncology Nursing
|
October 21, 2005
Factors affecting patient selection for prostate brachytherapy: what nurses should know
Debra Zeroski, Laurie Abel, Wayne M Butler, et al.
Journal of Contemporary Brachytherapy
|
January 28, 2016
Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
Gregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
The Journal of Urology
|
February 19, 2013
Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy
Nathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
World Journal of Urology
|
December 1, 2016
Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation
Gregory S Merrick, Robert W Galbreath, Abbey Bennett, et al.
Journal of Contemporary Brachytherapy
|
September 28, 2017
Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA
Gregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
Cancer Journal (Sudbury, Mass.)
|
August 3, 2004
Treatment margins predict biochemical outcomes after prostate brachytherapy
Seungtaek Choi, Kent E Wallner, Gregory S Merrick, et al.
American Journal of Clinical Oncology
|
December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mL
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy
|
April 6, 2004
Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation
Gregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 162) with videos related to
Sort By:
Page
of 17
Journal of Contemporary Brachytherapy
|
April 26, 2021
Effect of the timing of hydrogel spacer placement on prostate and rectal dosimetry of low-dose-rate brachytherapy implants
Wayne M Butler, Brian S Kurko, Whitney J Scholl, et al.
Oncology (Williston Park, N.Y.)
|
June 3, 2006
Permanent prostate brachytherapy: is supplemental external-beam radiation therapy necessary?
Gregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
Clinical Journal of Oncology Nursing
|
October 21, 2005
Factors affecting patient selection for prostate brachytherapy: what nurses should know
Debra Zeroski, Laurie Abel, Wayne M Butler, et al.
Journal of Contemporary Brachytherapy
|
January 28, 2016
Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
Gregory S Merrick, Wayne M Butler, Robert W Galbreath, et al.
The Journal of Urology
|
February 19, 2013
Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy
Nathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
World Journal of Urology
|
December 1, 2016
Incidence, grade and distribution of prostate cancer following transperineal template-guided mapping biopsy in patients with atypical small acinar proliferation
Gregory S Merrick, Robert W Galbreath, Abbey Bennett, et al.
Journal of Contemporary Brachytherapy
|
September 28, 2017
Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA
Gregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
Cancer Journal (Sudbury, Mass.)
|
August 3, 2004
Treatment margins predict biochemical outcomes after prostate brachytherapy
Seungtaek Choi, Kent E Wallner, Gregory S Merrick, et al.
American Journal of Clinical Oncology
|
December 4, 2004
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mL
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy
|
April 6, 2004
Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation
Gregory S Merrick, Wayne M Butler, Jonathan H Lief, et al.
Page
of 17